Role of the transcriptional intermediary factor TIF1g in vertebrate hematopoiesis
转录中间因子TIF1g在脊椎动物造血中的作用
基本信息
- 批准号:8511019
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-16 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAnemiaAnimalsBiochemicalBloodBypassCandidate Disease GeneCellsChromatinChromatin Remodeling FactorChromatin StructureCloningComplexDNA Polymerase IIDataDefectDevelopmentDiseaseElongation FactorEnvironmentEpigenetic ProcessErythroidErythropoiesisFunctional disorderGATA1 geneGene Expression RegulationGenesGeneticGenetic ProgrammingGenetic TranscriptionGlobinGoalsHematological DiseaseHematologyHematopoiesisHematopoieticHigher Order Chromatin StructureHistonesHumanKnockout MiceKnowledgeLeadLinkMalignant NeoplasmsMapsMediatingMentorsMessenger RNAMolecularNatureOrganismPathogenesisPathway interactionsPediatric HospitalsPhasePlayPolymeraseProcessRNA InterferenceRNA Polymerase IIRegulationResearchRoleStagingTestingTissuesTrainingTraining ProgramsTranscriptional Elongation FactorsZebrafishbasecareerchromatin immunoprecipitationchromatin modificationchromatin remodelingcohesincohesiondesignhuman diseaseimprovedinsightleukemiamedical schoolsmutantnoveloncologyprogenitorprogramstherapeutic targettranscription factortreatment strategy
项目摘要
Candidate Summary
My career goal is to direct an independent research group studying the nature and
function of chromatin factors that control hematopoietic cell fate. My research background in
epigenetic gene regulation plus my developing expertise in zebrafish genetics and
hematopoiesis provide me with the knowledge to perform the proposed research. The
training program in the hematology/oncology division at Children's Hospital and Harvard
Medical School provides an outstanding environment for the completion of training during the
mentored phase. This will greatly facilitate my smooth transition to independence.
Research Description
Hematopoiesis is controlled by complicated genetic programs involving tissue-specific
transcription factors and chromatin remodeling factors. Understanding the regulatory
mechanism of hematopoiesis provides significant insight into the pathophysiology of human
blood malignancies such as leukemia. The transcription intermediary factor TIF1¿ is a critical
factor for hematopoiesis yet the mechanism is not well understood. Through a large-scale
genetic suppressor screen using the zebrafish TIF1¿ mutant, I identified two suppressor
mutants that can bypass the requirement of TIF1¿ and restore blood in TIF1¿-deficient
animals. Initial characterizations of these mutants suggest a fundamental role of TIF1¿ in
regulating transcriptional elongation and chromatin remodeling during hematopoiesis. The
research described in this proposal is designed to elucidate the mechanism by which TIF1¿
regulates these processes. Aim1 will use chromatin immunoprecipitation (ChIP) analyses to
thoroughly examine the distribution of RNA polymerase II and associated histone markers on
blood genes in TIF1¿-deficient cells. Aim2 will use the available conditional knockout mice to
investigate the function of TIF1¿ and its suppressors in mammalian hematopoiesis. Aim3 will
focus on the in-depth characterization of the interaction between TIF1¿ and the cohesin
chromatin remodeling complex using genetic and biochemical approaches. Completion of
these aims will reveal the interplay among transcription factors, elongation factors and
chromatin remodelers during hematopoiesis. Given the involvement of transcriptional
elongation and chromatin modification in a variety of human disorders, these studies will
advance our understanding of their roles in the pathogenesis and progression of these
maladies and may also identify candidate genes or pathways that can be used for developing
novel targeted treatment strategies.
候选人摘要
我的职业目标是指导一个独立的研究小组,
控制造血细胞命运的染色质因子的功能。我的研究背景是
表观遗传基因调控加上我在斑马鱼遗传学方面的专业知识,
造血为我提供了进行拟议研究的知识。的
在儿童医院和哈佛的血液学/肿瘤学部门的培训计划
医学院提供了一个出色的环境,在培训期间完成
指导阶段。这将极大地促进我向独立的顺利过渡。
研究描述
造血是由复杂的遗传程序控制的,涉及组织特异性
转录因子和染色质重塑因子。了解监管
造血机制提供了重要的洞察人类的病理生理学
血液恶性肿瘤,如白血病。转录中介因子TIF 1 â是一个关键因素
造血因子,但其机制还不清楚。通过大规模
使用斑马鱼TIF 1 <$突变体进行遗传抑制筛选,我确定了两个抑制基因,
突变体,可以绕过TIF 1 <$$>的要求,并恢复TIF 1 <$-缺陷的血液
动物这些突变体的初步特征表明,TIF 1在以下方面发挥着重要作用:
调节造血过程中的转录延伸和染色质重塑。的
本提案中描述的研究旨在阐明TIF 1?
规范这些过程。Aim 1将使用染色质免疫沉淀(ChIP)分析,
彻底检查RNA聚合酶II和相关组蛋白标记物在
TIF 1缺陷细胞中的血液基因。Aim 2将使用可用的条件性基因敲除小鼠,
研究TIF 1 <$及其抑制因子在哺乳动物造血中的功能。AIM 3将
专注于深入表征TIF 1 <$和粘附素之间的相互作用,
染色质重塑复合物使用遗传和生物化学方法。完成
这些目标将揭示转录因子、延伸因子和转录因子之间的相互作用。
造血过程中的染色质重塑。鉴于转录的参与
延伸和染色质修饰在各种人类疾病,这些研究将
推进我们对它们在这些疾病的发病机制和进展中的作用的理解,
疾病,也可以确定候选基因或途径,可用于发展
新的靶向治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xiaoying Bai其他文献
Xiaoying Bai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xiaoying Bai', 18)}}的其他基金
Role of Transcription Pausing in Hematopoietic Stem Cell Development
转录暂停在造血干细胞发育中的作用
- 批准号:
8864909 - 财政年份:2015
- 资助金额:
$ 24.9万 - 项目类别:
Role of Transcription Pausing in Hematopoietic Stem Cell Development
转录暂停在造血干细胞发育中的作用
- 批准号:
9027844 - 财政年份:2015
- 资助金额:
$ 24.9万 - 项目类别:
Role of the transcriptional intermediary factor TIF1g in vertebrate hematopoiesis
转录中间因子TIF1g在脊椎动物造血中的作用
- 批准号:
8531914 - 财政年份:2012
- 资助金额:
$ 24.9万 - 项目类别:
Role of the transcriptional intermediary factor TIF1g in vertebrate hematopoiesis
转录中间因子TIF1g在脊椎动物造血中的作用
- 批准号:
8701282 - 财政年份:2012
- 资助金额:
$ 24.9万 - 项目类别:
Role of the transcriptional intermediary factor TIF1g in vertebrate hematopoiesis
转录中间因子TIF1g在脊椎动物造血中的作用
- 批准号:
8141989 - 财政年份:2010
- 资助金额:
$ 24.9万 - 项目类别:
Role of the transcriptional intermediary factor TIF1g in vertebrate hematopoiesis
转录中间因子TIF1g在脊椎动物造血中的作用
- 批准号:
7953331 - 财政年份:2010
- 资助金额:
$ 24.9万 - 项目类别:
相似国自然基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
- 批准号:82302715
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
- 批准号:31200592
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
- 批准号:
24K10442 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
- 批准号:
23K15297 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
- 批准号:
23K14452 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
- 批准号:
23KJ0074 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
- 批准号:
10752968 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
- 批准号:
10735765 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
- 批准号:
10735366 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
- 批准号:
10575222 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
- 批准号:
10583807 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
- 批准号:
10564553 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别: